It was manufactured by a well-known pharmaceutical company and may be used to treat a specific group of patients managing ...

The Food and Drug Administration has approved Journavx (suzetrigine) for the treatment of moderate to severe acute pain in adults.

Now a third option is available after the U.S. Food and Drug Administration last week approved Vertex Pharmaceuticals’ ...

Introducing Journavx: the FDA-approved non-opioid, non-addictive drug for acute pain. A major breakthrough in pain medication ...

The US Food and Drug Administration signed off Thursday on the first new type of pain reliever to be approved in more than two decades. The drug, suzetrigine, is a 50-milligram prescription pill ...

There's nothing quite like curling up with a great book on a cold winter's day –– and with the right reading tablet, your entire library is always within reach. You can choose from the ...

We may earn a commission if you make a purchase from the links on this page. Not many manufacturers are still pushing the boundaries in the premium tablet space, but Samsung continues to make waves ...

'ZDNET Recommends': What exactly does it mean? ZDNET's recommendations are based on many hours of testing, research, and comparison shopping. We gather data from the best available sources ...

A good gift doesn’t have to be an expensive gift, especially in this economy. And to prove it, we’ve pulled together 50 of our favorite things under $50 that we’ve written about — all of ...

Here’s how it works. Today's Android tablets are multitasking and gaming beasts, with stunning visuals and more customization options than Apple's best. Plus, tablets like the Samsung Galaxy Tab ...